Author

Yangsoo Jang

Professor of Cardiology, Severance Hospital. Dean, Yonsei University College of Medicine - Cited by 42,577 - cardiovascular disease - PCI - coronary stent - drug eluting balloon - chronic total occlusion

Biography

Dr. Yangsoo Jang is working at Cardiovascular Center of Medical College of Yonsei University which is located at Seoul, Republic of Korea. Yangsoo Jang’s research works mainly falls under the scope of aspects like cardiovascular disease, coronary stent, drug eluting balloon, chronic total occlusion and PCI.
Title
Cited by
Year
Optical coherence tomography in coronary atherosclerosis assessment and intervention
M Araki, SJ Park, HL Dauerman, S Uemura, JS Kim, C Di Mario, ...Nature Reviews Cardiology 19 (10), 684-703, 2022202
56
2022
Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic …
BK Kim, SJ Hong, YJ Lee, SJ Hong, KH Yun, BK Hong, JH Heo, SW Rha, ...The Lancet 400 (10349), 380-390, 2022202
51
2022
Management and outcomes of patients with left atrial appendage thrombus prior to percutaneous closure
L Marroquin, G Tirado-Conte, R Pracoń, W Streb, H Gutierrez, G Boccuzzi, ...Heart 108 (), 1098-1106, 2022202
14
2022
P2Y12 Inhibitor Monotherapy or Dual Antiplatelet Therapy After Complex Percutaneous Coronary Interventions
F Gragnano, R Mehran, M Branca, A Franzone, U Baber, Y Jang, ...Journal of the American College of Cardiology 81 (6), 537-552, 2023202
14
2023
Role of Intravascular Ultrasound‐Guided Percutaneous Coronary Intervention in Optimizing Outcomes in Acute Myocardial Infarction
Y Kim, SA Bae, TW Johnson, NH Son, DS Sim, YJ Hong, SW Kim, DK Cho, ...Journal of the American Heart Association 11 (5), e023481, 2022202
13
2022
Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: A meta-analysis of randomized trials
F Costa, C Montalto, M Branca, SJ Hong, H Watanabe, A Franzone, ...European Heart Journal 44 (11), 954-968, 2023202
12
2023
Ticagrelor monotherapy after 3-month dual antiplatelet therapy in acute coronary syndrome by high bleeding risk: the subanalysis from the TICO trial
YJ Lee, Y Suh, JS Kim, YH Cho, KH Yun, YH Kim, JY Cho, AY Her, S Cho, ...Korean Circulation Journal 52 (4), 324-337, 2022202
8
2022
A systematic review and meta-analysis of clinical outcomes of patients undergoing chronic total occlusion percutaneous coronary intervention
MD Bahadir Simsek, MD Spyridon Kostantinis, J Karacsonyi, ...Journal of Invasive Cardiology 34 (11), 2022202
6
2022
Impact of intravascular ultrasound in acute myocardial infarction patients at high ischemic risk
JW Roh, SA Bae, TW Johnson, Y Kim, DK Cho, JS Kim, BK Kim, D Choi, ...Revista Española de Cardiología (English Edition), 2022202
5
2022
Moderate-intensity statin with ezetimibe vs. high-intensity statin in patients with diabetes and atherosclerotic cardiovascular disease in the RACING trial
YJ Lee, JY Cho, SC You, YH Lee, KH Yun, YH Cho, WY Shin, SW Im, ...European Heart Journal (11), 972-983, 2023202
4
2023
Soluble RAGE attenuates Ang II-induced arterial calcification via inhibiting AT1R-HMGB1-RAGE axis
J Jeong, S Cho, M Seo, BS Lee, Y Jang, S Lim, S ParkAtherosclerosis 36, 53-62, 2022202
4
2022
Outcome of early versus delayed invasive strategy in patients with non-ST-segment elevation myocardial infarction and chronic kidney disease not on dialysis
YH Kim, AY Her, MH Jeong, BK Kim, SJ Hong, SJ Lee, CM Ahn, JS Kim, ...Atherosclerosis 44, 60-70, 2022202
3
2022
Platelet reactivity and clinical outcomes after drug-eluting stent implantation: Results from the PTRG-DES Consortium
SJ Lee, JJ Cha, YH Jeong, SJ Hong, CM Ahn, JS Kim, YG Ko, D Choi, ...Cardiovascular Interventions 15 (22), 225-2265, 2022202
3
2022
Assessment of fractional flow reserve in intermediate coronary stenosis using optical coherence tomography-based machine learning
JJ Cha, NL Nguyen, C Tran, WY Shin, SG Lee, YJ Lee, SJ Lee, SJ Hong, ...Frontiers in Cardiovascular Medicine 10, 1082214, 20220
3
2023
Dual antiplatelet therapy after percutaneous coronary intervention for left main coronary artery disease
S Cho, DY Kang, JS Kim, DW Park, IS Kim, TS Kang, JM Ahn, PH Lee, ...Revista Española de Cardiología (English Edition) 76 (4), 245-252, 20220
3
2023
Two‐year outcomes between ST‐elevation and non‐ST‐elevation myocardial infarction in patients with chronic kidney disease undergoing newer‐generation drug‐eluting stent …
YH Kim, AY Her, MH Jeong, BK Kim, SJ Hong, SJ Lee, CM Ahn, JS Kim, ...Catheterization and Cardiovascular Interventions 99 (4), 10-1037, 0
2
2022
Treat-to-Target or High-Intensity Statin in Patients With Coronary Artery Disease: A Randomized Clinical Trial
SJ Hong, YJ Lee, SJ Lee, BK Hong, WC Kang, JY Lee, JB Lee, TH Yang, ...JAMA 39 (13), 1078-1087, 030
2
2023
Long-term clinical outcomes between biodegradable and durable polymer drug-eluting stents: A nationwide cohort study
SJ Lee, DW Choi, Y Suh, SJ Hong, CM Ahn, JS Kim, BK Kim, YG Ko, ...Frontiers in Cardiovascular Medicine 9, 873114, 0
2
2022
Impact of one-month DAPT followed by aspirin monotherapy in patients undergoing percutaneous coronary intervention according to clinical presentation: a post hoc analysis of …
YJ Lee, JY Cho, KH Yun, SJ Lee, SJ Hong, CM Ahn, BK Kim, YG Ko, ...Eurointervention: Journal of Europcr in Collaboration with the Working Group …, 0
2
2022
Impact of Intravascular Ultrasound-Guided Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction and Chronic Kidney Disease
JW Roh, SA Bae, TW Johnson, SJ Heo, Y Kim, DK Cho, JS Kim, BK Kim, ...Circulation Journal, CJ-23-089, 2023202
1
2023

Referred From: https://scholar.google.com/citations?user=dLVTN4EAAAAJ&hl=en&oi=sra

Cited by
Citations 42577
h-index 97
i10-index 640
Recommended Journals
Open Access Journals